CHAPTER 6 152 SUPPLEMENTARY Known ER/PR expression and available for DNA analyses: vd Putten 2016: 485 patients v. Weelden 2021 study cohort: 83 patients Ravaggi 2022: 94 patients BRNO: 51 patients Talhouk 2015 & 2017: 265 patients Excluded based on failed molecular analysis: vd Putten 2016: 209 patients v. Weelden 2021 study cohort: 3 patients Ravaggi 2022 : 0 patients BRNO: 18 patients Talhouk 2015 & 2017: 1 patients 747 patients Excluded based on missing FU: Vd Putten 2016: 6 patients V Weelden 2021 study cohort: 2 patients Ravaggi 2022 : 0 patients BRNO: 0 patients Talhouk 2015 & 2017: 0 patients Total number of patients included in this study: 739 patients 978 patients Figure S1. Flowchart of the included patients from the five cohorts.
RkJQdWJsaXNoZXIy MTk4NDMw